Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In Vivo Vector Copy Number

Hematopoietic stem cell (HSC) gene therapy using integrating vectors has a potential leukemogenic risk due to insertional mutagenesis. To reduce this risk, a limitation of ≤2 average vector copy number (VCN) per cell is generally accepted. We developed an assay for VCN among transduced CD34(+) cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Naoya, Evans, Molly E, Hsieh, Matthew M, Bonifacino, Aylin C, Krouse, Allen E, Metzger, Mark E, Sellers, Stephanie E, Dunbar, Cynthia E, Donahue, Robert E, Tisdale, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Methods - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098567/
https://www.ncbi.nlm.nih.gov/pubmed/24045711
http://dx.doi.org/10.1038/mtna.2013.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098567/
https://www.ncbi.nlm.nih.gov/pubmed/24045711
http://dx.doi.org/10.1038/mtna.2013.49

Ejemplares similares